{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:30:18Z","timestamp":1786116618035,"version":"build-2736575974"},"reference-count":205,"publisher":"Elsevier","isbn-type":[{"value":"9780443345234","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019274","name":"National Institute of Mental Health and Neurosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apcsb.2025.10.012","type":"book-chapter","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:58:12Z","timestamp":1762383492000},"page":"135-167","source":"Crossref","is-referenced-by-count":0,"title":["Small molecular therapeutic targets for neurodegenerative diseases"],"prefix":"10.1016","author":[{"given":"Nagaraj","family":"Rangappa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathish","family":"Lakshman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivasamy","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murugan","family":"Sevanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Justin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-2129","authenticated-orcid":false,"given":"Subashchandrabose","family":"Chinnathambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jare.2014.11.008","article-title":"P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review","volume":"6","author":"Abdallah","year":"2015","journal-title":"Journal of Advanced Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","article-title":"Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders","volume":"8","author":"Abel","year":"2008","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuroscience.2025.06.037","article-title":"Role of blood-brain barrier in bacterial translocation","volume":"580","author":"Aborode","year":"2025","journal-title":"Neuroscience"},{"issue":"19","key":"10.1016\/bs.apcsb.2025.10.012_bib4","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.15252\/embj.201593411","article-title":"Tunneling nanotubes spread fibrillar \u03b1\u2010synuclein by intercellular trafficking of lysosomes","volume":"35","author":"Abounit","year":"2016","journal-title":"The EMBO Journal"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-04129-7","article-title":"Integrative machine learning and molecular simulation approaches identify GSK3\u03b2 inhibitors for neurodegenerative disease therapy","volume":"15","author":"Alhassan","year":"2025","journal-title":"Scientific Reports"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.012_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18368","article-title":"BDNF\/TrkB activators in Parkinson\u2019s disease: A new therapeutic strategy","volume":"28","author":"Ali","year":"2024","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"22","key":"10.1016\/bs.apcsb.2025.10.012_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216288","article-title":"Blood-brain barrier breakdown in Alzheimer\u2019s disease: Mechanisms and targeted strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12017-025-08857-x","article-title":"Unlocking Alzheimer\u2019s disease: The role of BDNF signaling in neuropathology and treatment","volume":"27","author":"Alqahtani","year":"2025","journal-title":"Neuromolecular Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib9","first-page":"169","article-title":"Chapter Seven - Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases","volume":"155","author":"Aman","year":"2020"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2025.07.003","article-title":"Mechanisms and routes of G-protein coupled receptor-mediated Tau degradation in Alzheimer\u2019s disease","author":"Ananthanarayana","year":"2025","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.trsl.2022.08.006","article-title":"NLRP3 inflammasome in neurodegenerative disease","volume":"252","author":"Anderson","year":"2023","journal-title":"Translational Research: the Journal of Laboratory and Clinical Medicine"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.012_bib12","doi-asserted-by":"crossref","first-page":"E1968","DOI":"10.1073\/pnas.1616070114","article-title":"Serum-borne bioactivity caused by pulmonary multiwalled carbon nanotubes induces neuroinflammation via blood\u2013brain barrier impairment","volume":"114","author":"Aragon","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.10.012_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111779","article-title":"Blood-brain barrier dysfunction in CNS disorders and putative therapeutic targets: An overview","volume":"13","author":"Archie","year":"2021","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.012_bib14","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.3390\/ijms23126827","article-title":"Recent advances on the role of brain-derived neurotrophic factor (BDNF) in neurodegenerative diseases","volume":"23","author":"Azman","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106972","article-title":"Catalyzing a cure: Discovery and development of LRRK2 inhibitors for the treatment of Parkinson\u2019s disease","volume":"143","author":"Baidya","year":"2024","journal-title":"Bioorganic Chemistry"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.10.012_bib16","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3233\/JPD-230432","article-title":"How Parkinson\u2019s disease-linked LRRK2 mutations affect different CNS cell types","volume":"14","author":"Bailey","year":"2024","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12964-021-00732-z","article-title":"Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer\u2019s disease","volume":"19","author":"Balmik","year":"2021","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"18","key":"10.1016\/bs.apcsb.2025.10.012_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169161","article-title":"Mitophagy in Neurons: Mechanisms regulating mitochondrial turnover and neuronal homeostasis","volume":"437","author":"Basak","year":"2025","journal-title":"Journal of Molecular Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nature Reviews Disease Primers"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.012_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062440","article-title":"Impact of peripheral inflammation on blood-brain barrier dysfunction and its role in neurodegenerative diseases","volume":"26","author":"Beltran-Velasco","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/620581","article-title":"Friends or foes: Matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases","volume":"2015","author":"Brkic","year":"2015","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/NDT.S75717","article-title":"Activation of mTOR: A culprit of Alzheimer\u2019s disease?","volume":"11","author":"Cai","year":"2015","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.012_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/STROKEAHA.110.600825","article-title":"Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment","volume":"42","author":"Candelario-Jalil","year":"2011","journal-title":"Stroke; a Journal of Cerebral Circulation"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107101","article-title":"The VEGFs\/VEGFRs system in Alzheimer\u2019s and Parkinson\u2019s diseases: Pathophysiological roles and therapeutic implications","volume":"201","author":"Ceci","year":"2024","journal-title":"Pharmacological Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib25","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/s41598-024-55923-8","article-title":"Emerging roles of SIRT1 activator, SRT2104, in disease treatment","volume":"14","author":"Chang","year":"2024","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib26","article-title":"Sirt1-Sirt3 axis regulates human blood-brain barrier permeability in response to ischemia","volume":"14","author":"Chen","year":"2017","journal-title":"Redox Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12987-024-00557-1","article-title":"Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases","volume":"21","author":"Chen","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.012_bib28","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s12640-021-00392-4","article-title":"SIRT1 protects dopaminergic neurons in Parkinson\u2019s Disease models via PGC-1\u03b1-mediated mitochondrial biogenesis","volume":"39","author":"Chen","year":"2021","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuroscience.2020.04.019","article-title":"G-Protein coupled receptors and tau-different roles in Alzheimer\u2019s disease","volume":"438","author":"Chidambaram","year":"2020","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bnd.2024.12.005","article-title":"LC3-associated endocytosis facilitates extracellular Tau aggregate internalization and degradation in microglia","volume":"1","author":"Chidambaram","year":"2025","journal-title":"Brain Network Disorders"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13578-020-00474-4","article-title":"Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation","volume":"10","author":"Chidambaram","year":"2020","journal-title":"Cell & Bioscience"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib32","series-title":"Advances in protein chemistry and structural biology","article-title":"Tau proteotasis in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib33","series-title":"Advances in clinical chemistry","article-title":"Tau and Amyloid beta causes microglial activation in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2025"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib34","series-title":"Advances in protein chemistry and structural biology","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/bs.apcsb.2024.07.001","article-title":"Chapter Twelve - Nuclear transport protein suppresses Tau neurodegeneration","volume":"143","author":"Chinnathambi","year":"2025"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2021.09.003","article-title":"Implications of valosin-containing protein in promoting autophagy to prevent Tau aggregation","volume":"476","author":"Chinnathambi","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib36","first-page":"201","article-title":"The cross-talk between ApoE and Tau protein in Alzheimer\u2019s disease","volume":"146","author":"Chinnathambi","year":"2025","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib37","first-page":"179","article-title":"Chapter Six - The aggregation propensity of Tau and amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"146","author":"Chinnathambi","year":"2025"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib38","series-title":"Advances in protein chemistry and structural biology","article-title":"Medicinal chemistry-based novel herapeutics for Tauopathies in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib39","series-title":"Advances in protein chemistry and structural biology","doi-asserted-by":"crossref","DOI":"10.1016\/bs.apcsb.2024.10.004","article-title":"SUMO inhibits Tau aggregation in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2025"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib40","first-page":"1","article-title":"Chapter One - Internalization of extracellular Tau oligomers in Alzheimer\u2019s disease","volume":"126","author":"Chinnathambi","year":"2025"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib41","series-title":"Advances in protein chemistry and structural biology","article-title":"G-protein coupled receptors (GPCRs) interacts with Tau protein in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib42","series-title":"Advances in protein chemistry and structural biology","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/bs.apcsb.2024.06.003","article-title":"Chapter Ten - Nuclear Tau accumulation in Alzheimer\u2019s disease","volume":"Vol. 143","author":"Chinnathambi","year":"2025"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.012_bib43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends in Pharmacological Sciences"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.10.012_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nature Reviews Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-016-0207-9","article-title":"Drug development in Alzheimer\u2019s disease: The path to 2025","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimer S Research & Therapy"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib46","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fddev.2022.855017","article-title":"Overcoming blood-brain barrier resistance: Implications for extracellular vesicle-mediated drug brain delivery [review]","volume":"2","author":"Dardet","year":"2022","journal-title":"Frontiers in Drug Delivery"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuroscience.2020.09.024","article-title":"Actin-mediated microglial chemotaxis via G-Protein coupled purinergic receptor in Alzheimer\u2019s disease","volume":"448","author":"Das","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/1759091420981204","article-title":"Melatonin reduces GSK3\u03b2-mediated Tau phosphorylation, enhances Nrf2 nuclear translocation and anti-inflammation","volume":"12","author":"Das","year":"2020","journal-title":"ASN Neuro"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.012_bib49","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer\u2019s disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9P-Linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib51","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ijbiomac.2020.10.226","article-title":"\u03b1-Linolenic acid inhibits Tau aggregation and modulates Tau conformation","volume":"166","author":"Desale","year":"2021","journal-title":"International Journal of Biological Macromolecules"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.012_bib52","first-page":"298","article-title":"Significance of P-Glycoproteins as a transporter system","volume":"1","author":"Dhavale","year":"2008","journal-title":"Research Journal of Pharmacy and Technology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2019.03.005","article-title":"Monomeric \u03b1-synuclein induces blood\u2013brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro","volume":"124","author":"Dohgu","year":"2019","journal-title":"Microvascular Research"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117176","article-title":"SIRT1: A novel regulator in colorectal cancer","volume":"178","author":"Dong","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123171","article-title":"Bacopa monnieri reduces Tau aggregation and Tau-mediated toxicity in cells","volume":"234","author":"Dubey","year":"2023","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112970","article-title":"The inhibitory effect of Curcumin-Artemisinin co-amorphous on Tau aggregation and Tau phosphorylation","volume":"221","author":"Dubey","year":"2023","journal-title":"Colloids and Surfaces. B, Biointerfaces"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.10.012_bib57","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nm1784","article-title":"Expression of a noncoding RNA is elevated in Alzheimer\u2019s disease and drives rapid feed-forward regulation of \u03b2-secretase","volume":"14","author":"Faghihi","year":"2008","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111869","article-title":"The NLRP3 inhibitor, OLT1177 attenuates brain injury in experimental intracerebral hemorrhage","volume":"131","author":"Fang","year":"2024","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101192","article-title":"The involvement of NLRP3 inflammasome in the treatment of Alzheimer\u2019s disease","volume":"64","author":"Feng","year":"2020","journal-title":"Ageing Research Reviews"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.012_bib60","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.tins.2023.07.006","article-title":"Alzheimer\u2019s disease and related tauopathies: Disorders of disrupted neuronal identity","volume":"46","author":"Frost","year":"2023","journal-title":"Trends in Neurosciences"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.012_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj7408","article-title":"Interaction of PINK1 with nucleotides and kinetin","volume":"10","author":"Gan","year":"2024","journal-title":"Science Advances"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1180913","article-title":"Early therapeutic effects of an Angiopoietin-1 mimetic peptide in middle-aged rats with vascular dementia","volume":"15","author":"Gao","year":"2023","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: A source of regional vulnerability in Parkinson\u2019s disease","volume":"15","author":"Ge","year":"2020","journal-title":"Molecular Neurodegeneration"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.012_bib64","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4155\/tde.15.32","article-title":"Molecular determinants of blood-brain barrier permeation","volume":"6","author":"Geldenhuys","year":"2015","journal-title":"Therapeutic Delivery"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib65","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/srep00150","article-title":"SIRT1 associates with eIF2-alpha and regulates the cellular stress response","volume":"1","author":"Ghosh","year":"2011","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.012_bib66","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0891-5849(02)00804-3","volume":"32","author":"Giasson","year":"2002","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116812","article-title":"Discovery of potent LRRK2 inhibitors by ensemble virtual screening strategy and bioactivity evaluation","volume":"279","author":"Gong","year":"2024","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2024.102856","article-title":"NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer","volume":"119","author":"Gonz\u00e1lez-Cota","year":"2024","journal-title":"Cell Calcium"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.012_bib69","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12031-018-1174-3","article-title":"Tau protein squired by molecular chaperones during Alzheimer\u2019s disease","volume":"66","author":"Gorantla","year":"2018","journal-title":"Journal of Molecular Neuroscience: MN"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.012_bib70","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10571-020-00897-0","article-title":"Autophagic pathways to clear the Tau aggregates in Alzheimer\u2019s disease","volume":"41","author":"Gorantla","year":"2021","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib71","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.ijbiomac.2019.11.176","article-title":"Transition metal nickel prevents Tau aggregation in Alzheimer\u2019s disease","volume":"156","author":"Gorantla","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib72","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/ADR-190118","article-title":"Neem derivatives inhibits Tau aggregation","volume":"3","author":"Gorantla","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease Reports"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4939-6598-4_2","article-title":"Global conformation of Tau protein mapped by Raman spectroscopy","volume":"1523","author":"Gorantla","year":"2017","journal-title":"Methods in Molecular Biology"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2025.10.012_bib74","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2013.12.020","article-title":"Epigenetic priming of memory updating during reconsolidation to attenuate remote fear memories","volume":"156","author":"Gr\u00e4ff","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib75","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrn3427","article-title":"Histone acetylation: Molecular mnemonics on the chromatin","volume":"14","author":"Graff","year":"2013","journal-title":"Nature Reviews. Neuroscience"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.012_bib76","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood\u2013brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.012_bib77","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s12264-023-01023-y","article-title":"NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson\u2019s disease","volume":"39","author":"Han","year":"2023","journal-title":"Neuroscience Bulletin"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.012_bib78","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1080\/15548627.2022.2139080","article-title":"PINK1-PRKN mediated mitophagy: Differences between in vitro and in vivo models","volume":"19","author":"Han","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102070","article-title":"The blood-brain barrier, a key bridge to treat neurodegenerative diseases","volume":"91","author":"Hang","year":"2023","journal-title":"Ageing Research Reviews"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.012_bib80","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-4580(96)00025-5","article-title":"Glycogen synthase kinase 3\u03b1 and 3\u03b2 do not colocalize with neurofibrillary tangles","volume":"17","author":"Harr","year":"1996","journal-title":"Neurobiology of Aging"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.012_bib81","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nature Reviews. Neuroscience"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib82","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bbmt.2018.09.015","article-title":"Cognitive function and quality of life in vorinostat-treated patients after matched unrelated donor myeloablative conditioning hematopoietic cell transplantation","volume":"25","author":"Hoodin","year":"2019","journal-title":"Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib83","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41401-022-00919-1","article-title":"Urolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation","volume":"44","author":"Huang","year":"2023","journal-title":"Acta Pharmacologica Sinica"},{"issue":"17","key":"10.1016\/bs.apcsb.2025.10.012_bib84","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/\u03b2-secretase expression","volume":"105","author":"H\u00e9bert","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib85","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-61779-551-0_7","article-title":"Conformations of microtubule-associated protein Tau mapped by fluorescence resonance energy transfer","volume":"849","author":"Jeganathan","year":"2012","journal-title":"Methods in Molecular Biology"},{"issue":"648","key":"10.1016\/bs.apcsb.2025.10.012_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj2658","article-title":"Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson\u2019s disease","volume":"14","author":"Jennings","year":"2022","journal-title":"Science Translational Medicine"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.012_bib87","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1021\/cr500457h","article-title":"Sirtuins in epigenetic regulation","volume":"115","author":"Jing","year":"2015","journal-title":"Chemical Reviews"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib88","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1196\/annals.1427.036","article-title":"The Nrf2\u2013ARE pathway: An indicator and modulator of oxidative stress in neurodegeneration","volume":"1147","author":"Johnson","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.012_bib89","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/187152709789824606","article-title":"Glutamate receptors as therapeutic targets for Parkinson\u2019s disease","volume":"8","author":"Johnson","year":"2009","journal-title":"CNS & Neurological Disorders Drug Targets"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.10.012_bib90","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"13","key":"10.1016\/bs.apcsb.2025.10.012_bib91","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","article-title":"SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer\u2019s disease and amyotrophic lateral sclerosis","volume":"26","author":"Kim","year":"2007","journal-title":"The EMBO Journal"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.012_bib92","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.3233\/JPD-223380","article-title":"Early-onset Parkinson\u2019s disease: Creating the right environment for a genetic disorder","volume":"12","author":"Kolicheski","year":"2022","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.012_bib93","article-title":"Potential of nerve growth factor (NGF)- and brain-derived neurotrophic factor (BDNF)-targeted gene therapy for Alzheimer\u2019s disease: A narrative review","volume":"17","author":"Koya","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.03.004","article-title":"Angioneurins \u2013 Key regulators of blood\u2013brain barrier integrity during hypoxic and ischemic brain injury","volume":"178","author":"Kunze","year":"2019","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib95","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16635","article-title":"New insights into the role of GSK-3\u03b2 in the brain: From neurodegenerative disease to tumorigenesis","volume":"11","author":"Lai","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2013.00016","article-title":"The role of sirtuins in Alzheimer\u2019s disease","volume":"5","author":"Lalla","year":"2013","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib97","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood\u2013brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib98","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fnmol.2020.00081","article-title":"GSK-3\u03b2 contributes to Parkinsonian dopaminergic neuron death: Evidence from conditional knockout mice and tideglusib","volume":"13","author":"Li","year":"2020","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101817","article-title":"PINK1\/Parkin-mediated mitophagy in neurodegenerative diseases","volume":"84","author":"Li","year":"2023","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib100","article-title":"The role of brain derived neurotrophic factor in central nervous system","volume":"14","author":"Li","year":"2022","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17010109","article-title":"Targeting brain drug delivery with macromolecules through receptor-mediated transcytosis","volume":"17","author":"Li","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115218","article-title":"TREM2: Potential therapeutic targeting of microglia for Alzheimer\u2019s disease","volume":"165","author":"Li","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib103","article-title":"NLRP3 inflammasome in Alzheimer\u2019s disease: Molecular mechanisms and emerging therapies","volume":"16","author":"Li","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib104","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","article-title":"The neurology of MTOR","volume":"84","author":"Lipton","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40035-015-0048-7","article-title":"7,8-Dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders","volume":"5","author":"Liu","year":"2016","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib106","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12951-025-03415-w","article-title":"Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood-brain barrier permeability","volume":"23","author":"Liu","year":"2025","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib107","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2020.02.074","article-title":"Disrupted blood-brain barrier in 5\u00d7FAD mouse model of Alzheimer\u2019s disease can be mimicked and repaired in vitro with neural stem cell-derived exosomes","volume":"525","author":"Liu","year":"2020","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib108","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fncel.2015.00226","article-title":"Histone acetylation modifiers in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Lu","year":"2015","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib109","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14348\/molcells.2016.2318","article-title":"Sirt1 and the Mitochondria","volume":"39","author":"Luen Tang","year":"2016","journal-title":"Molecules and Cells"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.012_bib110","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.conb.2011.09.001","article-title":"New developments on the role of NMDA receptors in Alzheimer\u2019s disease","volume":"22","author":"Malinow","year":"2012","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib111","series-title":"Receptor tyrosine kinases in neurodegenerative and psychiatric disorders","first-page":"353","article-title":"Chapter 10 - Repositioning of receptor tyrosine kinase inhibitors: From cancer to neurodegenerative and psychiatric disorders","author":"Mansour","year":"2023"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib112","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuint.2011.05.010","article-title":"Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3\u03b2","volume":"59","author":"Martin","year":"2011","journal-title":"Neurochemistry International"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-017-0170-3","article-title":"Quantitative proteomic analysis of Parkin substrates in Drosophila neurons","volume":"12","author":"Martinez","year":"2017","journal-title":"Molecular Neurodegeneration"},{"issue":"7761","key":"10.1016\/bs.apcsb.2025.10.012_bib114","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer\u2019s disease","volume":"570","author":"Mathys","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib115","article-title":"A leaky blood-brain barrier to fibrinogen contributes to oxidative damage in Alzheimer\u2019s disease","volume":"11","author":"McLarnon","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"29","key":"10.1016\/bs.apcsb.2025.10.012_bib116","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1523\/JNEUROSCI.0027-10.2010","article-title":"SIRT1 is essential for normal cognitive function and synaptic plasticity","volume":"30","author":"Mich\u00e1n","year":"2010","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib117","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2019.04.029","article-title":"Therapeutic approaches to enhance PINK1\/Parkin mediated mitophagy for the treatment of Parkinson\u2019s disease","volume":"705","author":"Miller","year":"2019","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106013","article-title":"Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics","volume":"136","author":"Mishra","year":"2021","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib119","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3389\/fnins.2018.01017","article-title":"Tau and mTOR: The hotspots for multifarious diseases in Alzheimer\u2019s development","volume":"12","author":"Mueed","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.012_bib120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric diseases","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.012_bib121","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1089\/ars.2010.3799","article-title":"Targeting mitochondrial dysfunction: Role for PINK1 and Parkin in mitochondrial quality control","volume":"14","author":"Narendra","year":"2011","journal-title":"Antioxidants & Redox Signaling"},{"issue":"14","key":"10.1016\/bs.apcsb.2025.10.012_bib122","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"348","author":"Nussbaum","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.012_bib123","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.3390\/ijms26104929","article-title":"Reversing epigenetic dysregulation in neurodegenerative diseases: Mechanistic and therapeutic considerations","volume":"26","author":"Olawade","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.012_bib124","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer\u2019s disease, vascular dementia and Parkinson\u2019s disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Current Alzheimer Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.012_bib126","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist\u2014a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105068","article-title":"Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders","volume":"148","author":"Paul","year":"2021","journal-title":"Neurochemistry International"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113700","article-title":"Arachidonic acid inhibition of the NLRP3 inflammasome is a mechanism to explain the anti-inflammatory effects of fasting","volume":"43","author":"Pereira","year":"2024","journal-title":"Cell Reports"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.012_bib130","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/glia.24654","article-title":"Lipids: Emerging players of microglial biology","volume":"73","author":"Prakash","year":"2025","journal-title":"Glia"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.redox.2017.02.007","article-title":"Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity","volume":"12","author":"Prasad","year":"2017","journal-title":"Redox Biology"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.012_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119275","article-title":"Histone deacetylase-6 modulates Tau function in Alzheimer\u2019s disease","volume":"1869","author":"Qureshi","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib133","series-title":"Advances in protein chemistry and structural biology","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/bs.apcsb.2024.09.009","article-title":"Chapter Fourteen - Nuclear podosomes regulates cellular migration in Tau and Alzheimer\u2019s disease","volume":"143","author":"Qureshi","year":"2025"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020279","article-title":"Transferrin Receptor-targeted nanocarriers: Overcoming barriers to treat glioblastoma","volume":"14","author":"Ramalho","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2018.01.021","article-title":"Traumatic brain injury and Alzheimer\u2019s disease: The cerebrovascular link","volume":"28","author":"Ramos-Cejudo","year":"2018","journal-title":"eBioMedicine"},{"issue":"6301","key":"10.1016\/bs.apcsb.2025.10.012_bib136","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science (New York, N. Y.)"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.012_bib137","article-title":"The role of sirtuin 1 (SIRT1) in neurodegeneration","volume":"15","author":"Razick","year":"2023","journal-title":"Cureus"},{"issue":"6415","key":"10.1016\/bs.apcsb.2025.10.012_bib138","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.012_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052793","article-title":"Microglial Activation damages dopaminergic neurons through MMP-2\/-9-mediated increase of blood-brain barrier permeability in a Parkinson\u2019s disease mouse model","volume":"23","author":"Ruan","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.10.012_bib140","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2174\/1570159X16666180222165418","article-title":"The role of LRRK2 in neurodegeneration of Parkinson disease","volume":"16","author":"Rui","year":"2018","journal-title":"Current Neuropharmacology"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.012_bib141","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/cancers14061382","article-title":"Occurrence of total and proteinase K-resistant alpha-synuclein in glioblastoma cells depends on mTOR activity","volume":"14","author":"Ryskalin","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib142","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","article-title":"Blood-brain barrier tight junction permeability and ischemic stroke","volume":"32","author":"Sandoval","year":"2008","journal-title":"Neurobiology of Disease"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.10.012_bib143","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1474-4422(23)00247-8","article-title":"Stimulation of TREM2 with agonistic antibodies\u2014an emerging therapeutic option for Alzheimer\u2019s disease","volume":"22","author":"Schlepckow","year":"2023","journal-title":"The Lancet Neurology"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.012_bib144","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Molecular Medicine"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.012_bib145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer\u2019s disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathology (Zurich, Switzerland)"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115145","article-title":"Breviscapine regulates lipid metabolism of microglia via the ADORA1\/PPAR\u03b1\/ACOX1 pathway to promote spinal cord injury recovery","volume":"162","author":"Shi","year":"2025","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib147","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2147\/JIR.S503428","article-title":"Fingolimod suppresses NLRP3 inflammasome activation and alleviates oxidative stress in traumatic brain injury-induced acute lung injury","volume":"18","author":"Shi","year":"2025","journal-title":"Journal of Inflammation Research"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.012_bib148","doi-asserted-by":"crossref","first-page":"688","DOI":"10.34172\/apb.2023.071","article-title":"Role of GSK-3\u03b2 inhibitors: New promises and opportunities for Alzheimer\u2019s disease","volume":"13","author":"Shri","year":"2023","journal-title":"Advanced Pharmaceutical Bulletin"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib149","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fphar.2020.00537","article-title":"Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation [review]","volume":"11","author":"Shukla","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2018.06.010","article-title":"LRRK2 and mitochondria: Recent advances and current views","volume":"1702","author":"Singh","year":"2019","journal-title":"Brain Research"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib151","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib152","doi-asserted-by":"crossref","DOI":"10.1039\/D5MD00167F","article-title":"NLRP3 inflammasome: Structure, mechanism, drug-induced organ toxicity, therapeutic strategies, and future perspectives","author":"Singh","year":"2025","journal-title":"RSC Med Chem"},{"issue":"14","key":"10.1016\/bs.apcsb.2025.10.012_bib153","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143433","article-title":"Cerebrovascular and neurological disorders: Protective role of NRF2","volume":"20","author":"Sivandzade","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.012_bib154","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12031-018-1111-5","article-title":"Prion-like propagation of post-translationally modified Tau in Alzheimer\u2019s disease: A hypothesis","volume":"65","author":"Sonawane","year":"2018","journal-title":"Journal of Molecular Neuroscience: MN"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.10.012_bib155","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.18632\/oncotarget.27963","article-title":"Epigallocatechin-3-gallate modulates Tau post-translational modifications and cytoskeletal network","volume":"12","author":"Sonawane","year":"2021","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib156","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12964-021-00704-3","article-title":"Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation","volume":"19","author":"Sonawane","year":"2021","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib157","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fncel.2017.00063","article-title":"NLRP3 inflammasome in neurological diseases, from functions to therapies","volume":"11","author":"Song","year":"2017","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.012_bib158","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nature Neuroscience"},{"issue":"6645","key":"10.1016\/bs.apcsb.2025.10.012_bib159","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nbd.2018.09.006","article-title":"Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging","volume":"126","author":"Stamatovic","year":"2019","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib161","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-025-00478-5","article-title":"Blood-brain barrier disruption: A pervasive driver and mechanistic link between traumatic brain injury and Alzheimer\u2019s disease","volume":"14","author":"Sun","year":"2025","journal-title":"Translational Neurodegeneration"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.012_bib162","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5580","article-title":"Lipid metabolism in microglia: Emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (Review)","volume":"56","author":"Sun","year":"2025","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib163","series-title":"Biomarkers and bioanalysis overview","article-title":"P-Glycoprotein efflux transporters and its resistance its inhibitors and therapeutic aspects","author":"Sureshkumar","year":"2020"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.012_bib164","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease","volume":"62","author":"Swerdlow","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.012_bib165","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.14336\/AD.2022.0130-1","article-title":"Discerning the role of blood brain barrier dysfunction in Alzheimer\u2019s disease","volume":"13","author":"Tao","year":"2022","journal-title":"Aging and disease"},{"issue":"7628","key":"10.1016\/bs.apcsb.2025.10.012_bib166","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: From genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102545","article-title":"The role of sirtuin 1 in ageing and neurodegenerative disease: A molecular perspective","volume":"102","author":"Thapa","year":"2024","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib168","first-page":"367","article-title":"Memantine: A review of studies into its safety and efficacy in treating Alzheimer\u2019s disease and other dementias","volume":"4","author":"Thomas","year":"2009","journal-title":"Clinical Interventions in Aging"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib169","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-021-00450-7","article-title":"Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain","volume":"16","author":"Toker","year":"2021","journal-title":"Molecular Neurodegeneration"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.012_bib170","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre\u2010clinical AD, amnestic mild cognitive impairment and late\u2010stage AD","volume":"133","author":"Tramutola","year":"2015","journal-title":"Journal of Neurochemistry"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.10.012_bib171","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1007\/s12035-024-04003-z","article-title":"Therapeutic potential effect of glycogen synthase kinase 3 Beta (GSK-3\u03b2) inhibitors in Parkinson disease: Exploring an overlooked avenue","volume":"61","author":"Turkistani","year":"2024","journal-title":"Molecular Neurobiology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib172","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","article-title":"Elucidating the role of TREM2 in Alzheimer\u2019s disease","volume":"94","author":"Ulrich","year":"2017","journal-title":"Neuron"},{"issue":"5674","key":"10.1016\/bs.apcsb.2025.10.012_bib173","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science (New York, N. Y.)"},{"issue":"5918","key":"10.1016\/bs.apcsb.2025.10.012_bib174","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science (New York, N. Y.)"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1681\/ASN.2013010069","article-title":"Endothelial sirtuin 1 deficiency perpetrates nephrosclerosis through downregulation of matrix metalloproteinase-14: Relevance to fibrosis of vascular senescence","volume":"25","author":"Vasko","year":"2014","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.012_bib176","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1177\/0963689718791568","article-title":"Angiopoietin-1 mimetic peptide promotes neuroprotection after stroke in type 1 diabetic rats","volume":"27","author":"Venkat","year":"2018","journal-title":"Cell Transplantation"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib177","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fnins.2020.00443","article-title":"LRRK2 at the interface between peripheral and central immune function in Parkinson\u2019s","volume":"14","author":"Wallings","year":"2020","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111700","article-title":"Edaravone dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltration","volume":"130","author":"Wang","year":"2024","journal-title":"International Immunopharmacology"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.10.012_bib179","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/antiox11071304","article-title":"mTOR signalling pathway: A potential therapeutic target for ocular neurodegenerative diseases","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115962","article-title":"TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury","volume":"170","author":"Wei","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.012_bib182","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.apsb.2025.01.015","article-title":"Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer\u2019s disease","volume":"15","author":"Wei","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib183","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fnagi.2024.1308577","article-title":"Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson\u2019s disease (ROCK-PD) [Study Protocol]","volume":"16","author":"Wolff","year":"2024","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib184","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: Structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-024-02696-z","article-title":"The contribution of \u03b2-amyloid, Tau and \u03b1-synuclein to blood-brain barrier damage in neurodegenerative disorders","volume":"147","author":"Wu","year":"2024","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib186","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/648740","article-title":"Shared mechanisms of neurodegeneration in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"2014","author":"Xie","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib187","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1366061","article-title":"Pharmacological mTOR inhibitors in ameliorating Alzheimer\u2019s disease: Current review and perspectives","volume":"15","author":"Xie","year":"2024","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib188","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2018.05.016","article-title":"Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury","volume":"117","author":"Xu","year":"2018","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib189","first-page":"143","article-title":"Chapter Four - Transcriptional regulation of metabolism by SIRT1 and SIRT7","volume":"335","author":"Yamagata","year":"2018"},{"issue":"14","key":"10.1016\/bs.apcsb.2025.10.012_bib190","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2174\/1570159X22666240128002056","article-title":"Emerging neuroprotective strategies: Unraveling the potential of HDAC inhibitors in traumatic brain injury management","volume":"22","author":"Ye","year":"2024","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib191","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fnins.2024.1481983","article-title":"Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases [review]","volume":"18","author":"Ye","year":"2024","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1209703","article-title":"The role of glycogen synthase kinase 3 beta in neurodegenerative diseases","volume":"16","author":"Yu","year":"2023","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib193","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/s12967-025-06799-3","article-title":"TREM2-mediated regulation of microglial activity: A promising target for the treatment of ischemic stroke","volume":"23","author":"Yu","year":"2025","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib194","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer\u2019s disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114671","article-title":"Urolithin A alleviates radiation pneumonitis by activating PINK1\/PRKN-mediated mitophagy","volume":"156","author":"Zhang","year":"2025","journal-title":"International Immunopharmacology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib196","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-025-00834-z","article-title":"TREM2 and sTREM2 in Alzheimer\u2019s disease: From mechanisms to therapies","volume":"20","author":"Zhang","year":"2025","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114474","article-title":"Therapeutic potential of natural molecules against Alzheimer\u2019s disease via SIRT1 modulation","volume":"161","author":"Zhang","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.012_bib198","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.apsb.2022.01.008","article-title":"Impairment of the autophagy\u2013lysosomal pathway in Alzheimer\u2019s diseases: Pathogenic mechanisms and therapeutic potential","volume":"12","author":"Zhang","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108888","article-title":"N-methyl-D-aspartate receptors (NMDARs): A glutamate-activated cation channel with biased signaling and therapeutic potential in brain disorders","volume":"273","author":"Zhang","year":"2025","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apcsb.2025.10.012_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105639","article-title":"Role of trigger receptor 2 expressed on myeloid cells in neuroinflammation\uff0dneglected multidimensional regulation of microglia","volume":"171","author":"Zhang","year":"2023","journal-title":"Neurochemistry International"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.012_bib201","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbrc.2018.03.226","article-title":"TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson\u2019s disease","volume":"499","author":"Zhang","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib202","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","article-title":"TNF-\u03b1 knockout and minocycline treatment attenuates blood\u2013brain barrier leakage in MPTP-treated mice","volume":"26","author":"Zhao","year":"2007","journal-title":"Neurobiology of Disease"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.012_bib203","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3390\/biom14101204","article-title":"Astrocyte-mediated neuroinflammation in neurological conditions","volume":"14","author":"Zhao","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.012_bib204","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","article-title":"Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease","volume":"26","author":"Zhou","year":"2020","journal-title":"Nature Medicine"},{"issue":"5529","key":"10.1016\/bs.apcsb.2025.10.012_bib205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science (New York, N. Y.)"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Molecular targets and therapeutic design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:45:04Z","timestamp":1786013104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162325000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443345234"],"references-count":205,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2025.10.012","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}